Prometheus gets US rights to Rosetta's microRNA-based tests
- Antisense, Oligonucleotides
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Specialty Pharmaceuticals
- Intra-Biotech Deal
- R+D and Marketing-Licensing
- Includes Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.